Close

Wedbush Securities to Host Its Annual PacGrow Healthcare Management Access Conference in August 2015 Aug 4, 2015 01:55PM
Pre-Open Stock Movers 8/25: (ITMN) (THI) (BKW) (LTM) Higher; (RGDO) (QIHU) (THOR) Lower (more...) Aug 25, 2014 09:29AM
Roche's (RHHBY) Genentech Receives FDA Approval for Gazyva Nov 1, 2013 09:44AM
Roche (RHHBY) Halts Development of Diabetes Drug Aleglitazar Following Phase III Jul 10, 2013 06:37AM
Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta Jul 2, 2013 06:39AM


Apr 30, 2013 11:31AM Roche's (RHHBY) Genentech Receives FDA Approval for ACTEMRA as PJIA Treatment
Oct 12, 2012 11:32AM Roche's (RHHBY) Genentech Receives Expanded Indication for ACTEMRA
May 7, 2012 08:06AM Roche (RHHBY) to Stop Dalcetrapib dal-OUTCOMES Phase III Trial
Apr 27, 2012 09:26AM Competition, Spending Cuts Make Illumina (ILMN) One Risky Play - Barron's
Mar 19, 2012 04:47PM Novartis (NVS) Could Formulate Strong Results in 2012 - Barron's
Oct 20, 2011 01:00AM Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years
Aug 10, 2010 03:10PM Roche' (RHHBY) Genentech Gets U.S. FDA Approval for Lengthening Therapy with Valcyte in Kidney Transplant Patients With High-Risk of CMV Disease
Jun 7, 2010 07:38AM Roche's (RHHBY) Genentech Announces Positive Data in Avastin Phase III in Women with Ovarian Cancer
May 20, 2010 01:49PM Roche Group's (RHHBY) Genetech and Biogen Itec (BIIB) Announce Positive Data from Rituxan Phase III
May 19, 2010 06:52AM Roche (RHHBY) and Biogen Idec (BIIB) Announce Discontinuation of Ocrelizumab Development Program